Calidi Biotherapeutics (CLDI) EPS (Diluted) (2022 - 2026)
Analysis
Calidi Biotherapeutics (CLDI) EPS (Diluted) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | 1.79 |
| 2 | CRISPR Therapeutics AG | 5.03 Bn | 5.03 Bn | - | -0.94 |
| 3 | Iovance Biotherapeutics | 3.66 Bn | 3.36 Bn | 55.72 Mn | -0.11 |
| 4 | Legend Biotech | 3.54 Bn | 2.57 Bn | 251.50 Mn | 0.42 |
| 5 | uniQure | 3.02 Bn | 3.02 Bn | 5.49 Mn | -1.22 |
| 6 | Beam Therapeutics | 2.54 Bn | 2.54 Bn | - | -1.18 |
| 7 | Precigen | 2.38 Bn | 2.38 Bn | 52.17 Mn | 0.05 |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn | -0.05 |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn | 0.04 |
| 10 | Calidi Biotherapeutics | 1.88 Mn | -2.22 Mn | - | -2.94 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.94 |
| Dec 31, 2025 | -15.09 |
| Sep 30, 2025 | -35.29 |
| Jun 30, 2025 | -31.78 |
| Mar 31, 2025 | -35.34 |
| Dec 31, 2024 | -98.27 |
| Sep 30, 2024 | -124.03 |
| Jun 30, 2024 | -268.05 |
| Mar 31, 2024 | -390.22 |
| Dec 31, 2023 | -935.65 |
| Sep 30, 2023 | -271.57 |
| Jun 30, 2023 | -1,214.99 |
| Mar 31, 2023 | -628.05 |
| Dec 31, 2022 | -842.59 |
| Sep 30, 2022 | -495.65 |
| Jun 30, 2022 | 347.38 |
| Mar 31, 2022 | 122.06 |